AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25890835 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 IU hCG 4 days post TAI (D4) in multiparous cows
Number of subjects: 406
Study 25890835 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment groups (D4 and D6)
Number of subjects: 406
Study 23885991 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycomacropeptide (GMP)
Number of subjects: 18
Study 23885991 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta‐lactoglobulin (ß‐lac)
Number of subjects: 18
Study 23885991 — intervention group
Group type: EXPERIMENTAL
Intervention: Colostrum whey protein concentrate (WPC)
Number of subjects: 18
Study 23885991 — intervention group
Group type: COMPARATOR
Intervention: WPC control
Number of subjects: 18
Study 22084264 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient activation and physician decision support tool
Number of subjects: 4105
Study 22084264 — intervention group
Group type: EXPERIMENTAL
Intervention: High use of patient activation kiosk
Number of subjects: 4105
Study 22084264 — intervention group
Group type: EXPERIMENTAL
Intervention: High use of decision support tools by physicians
Number of subjects: 4105
Study 19554711 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 58
Study 19554711 — intervention group
Group type: COMPARATOR
Intervention: Subgingival ultrasound only (Control)
Number of subjects: 58
Study 17713337 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Duraphat) applied twice-yearly at school for 26 months
Number of subjects: 664
Study 17713337 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fluoride varnish)
Number of subjects: 664
Study 14604835 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography for detection and surveillance of small abdominal aortic aneurysms
Number of subjects: 0
Study 14604835 — intervention group
Group type: EXPERIMENTAL
Intervention: Early, open, elective surgery for small aneurysms
Number of subjects: 0
Study 14604835 — intervention group
Group type: EXPERIMENTAL
Intervention: Open or endovascular surgery for aneurysms exceeding 5.5 cm
Number of subjects: 0
Study 14604835 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatments to reduce expansion rate by >50%
Number of subjects: 0
Study 14604835 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins as a proposed treatment
Number of subjects: 0
Study 12439840 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid treatment for 6 months
Number of subjects: 18
Study 12439840 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppressive drugs
Number of subjects: 18
Study 12439840 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 18
Study 12439840 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids and azathioprine
Number of subjects: 18
Study 12439840 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroids and cyclophosphamide
Number of subjects: 18
Study 10353328 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg folic acid
Number of subjects: 4
Study 10353328 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg vitamin B6
Number of subjects: 4
Study 10353328 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 0.3 mg folic acid and 120 mg vitamin B6
Number of subjects: 4
Study 10353328 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg folic acid
Number of subjects: 4
Study 7477145 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy alone
Number of subjects: 2105
Study 7477145 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy plus breast irradiation
Number of subjects: 2105
Study 7477145 — intervention group
Group type: COMPARATOR
Intervention: Total mastectomy
Number of subjects: 2105
Study 1934661 — intervention group
Group type: EXPERIMENTAL
Intervention: D + W (dipyridamole and low-dose warfarin)
Number of subjects: 48
Study 1934661 — intervention group
Group type: COMPARATOR
Intervention: Control group (cessation of D + W)
Number of subjects: 48
Study 1934661 — intervention group
Group type: COMPARATOR
Intervention: Original treatment group (27 patients)
Number of subjects: 48
Study 1934661 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment group (n = 13)
Number of subjects: 48
Study 6119937 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol (beta-blocker with intrinsic sympathomimetic activity)
Number of subjects: 0
Study 6119937 — intervention group
Group type: COMPARATOR
Intervention: beta-blockers without intrinsic sympathomimetic activity
Number of subjects: 0
Study 6145932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal air oscillation at 8 Hz
Number of subjects: 0
Study 6145932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal air oscillation at 14 Hz
Number of subjects: 0
Study 6145932 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal air oscillation at 20 Hz
Number of subjects: 0
Study 31987567 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (performed at ST34, ST36, and LR3)
Number of subjects: 45
Study 31987567 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham acupuncture (performed at three nontraditional points)
Number of subjects: 45
Study 31987567 — intervention group
Group type: COMPARATOR
Intervention: Control group (resting for 2 minutes without treatment)
Number of subjects: 45
Study 28800211 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic dofetilide 0.5 mg
Number of subjects: 73
Study 28800211 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation
Number of subjects: 73
Study 27120408 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-gripping mesh
Number of subjects: 363
Study 27120408 — intervention group
Group type: COMPARATOR
Intervention: Standard polypropylene mesh
Number of subjects: 363
Study 24840659 — intervention group
Group type: EXPERIMENTAL
Intervention: Nighttime bending brace treatment
Number of subjects: 37
Study 24840659 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 37
Study 22339294 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician delivering HIV/AIDS messages using a combined statistical/emotional format
Number of subjects: 0
Study 22339294 — intervention group
Group type: COMPARATOR
Intervention: Minister delivering HIV/AIDS messages (not explicitly detailed in outcomes)
Number of subjects: 0
Study 22339294 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed and loss-framed information (not explicitly detailed in outcomes)
Number of subjects: 0
Study 20555283 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex Set (CS)
Number of subjects: 18
Study 20555283 — intervention group
Group type: COMPARATOR
Intervention: Traditional Set (TS)
Number of subjects: 18
Study 18455944 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound (US)
Number of subjects: 49
Study 18455944 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound (sham US)
Number of subjects: 49
Study 16454443 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with OSA
Number of subjects: 36
Study 16454443 — intervention group
Group type: COMPARATOR
Intervention: Control group (snoring persons)
Number of subjects: 36
Study 16454443 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with OSA (male group)
Number of subjects: 36
Study 16454443 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with OSA (female group)
Number of subjects: 36
Study 14641839 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 546
Study 14641839 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected children
Number of subjects: 546
Study 14641839 — intervention group
Group type: COMPARATOR
Intervention: HIV-uninfected children
Number of subjects: 546
Study 14641839 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV positive children
Number of subjects: 546
Study 10648325 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine during propofol anesthesia (n = 10)
Number of subjects: 31
Study 10648325 — intervention group
Group type: COMPARATOR
Intervention: Saline during propofol anesthesia (n = 6)
Number of subjects: 31
Study 10648325 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia (Group D, n = 7)
Number of subjects: 31
Study 10648325 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-ketamine anesthesia (Group E, n = 8)
Number of subjects: 31
Study 10648325 — intervention group
Group type: COMPARATOR
Intervention: Awake (Group C, n = 7)
Number of subjects: 31
Study 8690819 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoprostenol
Number of subjects: 30
Study 8690819 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone
Number of subjects: 30
Study 2066441 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline-immobilized cross-linked collagen film (TC film) administered 4 times at 1-week intervals
Number of subjects: 16
Study 2066441 — intervention group
Group type: EXPERIMENTAL
Intervention: Root planing (RP) treatment
Number of subjects: 16
Study 2066441 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (TC + RP)
Number of subjects: 16
Study 2066441 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 16
Study 6367861 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months of adjuvant chemotherapy with CMF
Number of subjects: 308
Study 6367861 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 months of adjuvant chemotherapy with CMF
Number of subjects: 308
Study 6367861 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months of CMF preceded by local-regional x-ray therapy (XRT)
Number of subjects: 308
Study 6367861 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 months of CMF
Number of subjects: 308
Study 6367861 — intervention group
Group type: COMPARATOR
Intervention: Combined two non-XRT arms (6 months CMF and 6 months CMF with XRT)
Number of subjects: 308
Study 6367861 — intervention group
Group type: EXPERIMENTAL
Intervention: XRT treatment arm
Number of subjects: 308
Study 31601357 — intervention group
Group type: EXPERIMENTAL
Intervention: RAFT - group cognitive-behavioural therapy (CBT) programme delivered by rheumatology tutor pairs (nurses/occupational therapists)
Number of subjects: 333
Study 31601357 — intervention group
Group type: COMPARATOR
Intervention: Usual care - brief discussion of a RA fatigue self-management booklet with the research nurse
Number of subjects: 333
Study 31601357 — intervention group
Group type: EXPERIMENTAL
Intervention: RAFT - group CBT programme
Number of subjects: 333
Study 31601357 — intervention group
Group type: COMPARATOR
Intervention: Usual care - brief discussion of a RA fatigue self-management booklet
Number of subjects: 333
Study 30373553 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 L Physioneal 1.36% glucose dialysis fluid
Number of subjects: 10
Study 30373553 — intervention group
Group type: COMPARATOR
Intervention: 2 L Physioneal 3.86% glucose dialysis fluid
Number of subjects: 10
Study 30373553 — intervention group
Group type: EXPERIMENTAL
Intervention: Both glucose concentrations (1.36% and 3.86%)
Number of subjects: 10
Study 27040693 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body power training (PT)
Number of subjects: 20
Study 27040693 — intervention group
Group type: COMPARATOR
Intervention: Lower body power training followed by 30 min of low‐intensity running (PET)
Number of subjects: 20
Study 24527531 — intervention group
Group type: EXPERIMENTAL
Intervention: On-time dosing of tadalafil (10 mg/20 mg, twice a week for 8 weeks)
Number of subjects: 120
Study 24527531 — intervention group
Group type: COMPARATOR
Intervention: On-demand dosing of tadalafil (10 mg/20 mg before sexual activity)
Number of subjects: 120
Study 22205307 — intervention group
Group type: EXPERIMENTAL
Intervention: 1200 mg n-3 LCPUFAs as a supplement per day and a concomitant reduction in arachidonic acid intake
Number of subjects: 208
Study 22205307 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 208
Study 20970603 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily prolonged-release tacrolimus (QD)
Number of subjects: 27
Study 20970603 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily tacrolimus (BID)
Number of subjects: 27
Study 17686103 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 100
Study 17686103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 16366757 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 2.5 mg/kg p.o.
Number of subjects: 0
Study 16366757 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 5.0 mg/kg p.o.
Number of subjects: 0
Study 16366757 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (20 microg/kg)
Number of subjects: 0
Study 16366757 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0)
Number of subjects: 0
Study 16366757 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine and nicotine
Number of subjects: 0
Study 11923693 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 0.75 mg bid
Number of subjects: 695
Study 11923693 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 1.5 mg bid
Number of subjects: 695
Study 11923693 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus (both dosages)
Number of subjects: 695
Study 9695999 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 527
Study 9695999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 527
Study 8005290 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progestin
Number of subjects: 0
Study 8005290 — intervention group
Group type: EXPERIMENTAL
Intervention: IM progestin
Number of subjects: 0
Study 8005290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dydrogesterone
Number of subjects: 0
Study 2658177 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine (50 mg intravenously every 6 hours for 72 hours)
Number of subjects: 83
Study 2658177 — intervention group
Group type: COMPARATOR
Intervention: No ranitidine treatment (control group)
Number of subjects: 83
Study 2658177 — intervention group
Group type: COMPARATOR
Intervention: Transfused patients
Number of subjects: 83
Study 1103210 — intervention group
Group type: EXPERIMENTAL
Intervention: frontalis EMG biofeedback (variable frequency auditory feedback)
Number of subjects: 101
Study 1103210 — intervention group
Group type: EXPERIMENTAL
Intervention: passive relaxation instructions (instructions to attend to and relax muscles)
Number of subjects: 101
Study 1103210 — intervention group
Group type: EXPERIMENTAL
Intervention: active relaxation instructions (tensing and relaxing exercises)
Number of subjects: 101
Study 1103210 — intervention group
Group type: EXPERIMENTAL
Intervention: false feedback
Number of subjects: 101
Study 1103210 — intervention group
Group type: COMPARATOR
Intervention: no treatment control
Number of subjects: 101
Study 31846094 — intervention group
Group type: EXPERIMENTAL
Intervention: Postsurgical reconstruction
Number of subjects: 273
Study 31846094 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-prosthetic rehabilitation
Number of subjects: 273
Study 31846094 — intervention group
Group type: COMPARATOR
Intervention: Post-rhinectomy nasal defect
Number of subjects: 273
Study 31846094 — intervention group
Group type: COMPARATOR
Intervention: Monocular blindness
Number of subjects: 273
Study 31846094 — intervention group
Group type: COMPARATOR
Intervention: Binocular blindness
Number of subjects: 273
Study 31318745 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror-aided cross-education
Number of subjects: 32
Study 31318745 — intervention group
Group type: COMPARATOR
Intervention: Cross-education alone
Number of subjects: 32
Study 28280731 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapered implant with knife‐edge threads/nanostructured calcium‐incorporated surface (Anyridge®, Megagen)
Number of subjects: 10
Study 28280731 — intervention group
Group type: COMPARATOR
Intervention: Cylindrical implant with self‐tapping threads/sandblasted surface (EZPlus®, Megagen)
Number of subjects: 10
Study 26537979 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 90
Study 26537979 — intervention group
Group type: EXPERIMENTAL
Intervention: Horticultural activity
Number of subjects: 90
Study 26537979 — intervention group
Group type: COMPARATOR
Intervention: Educational control group
Number of subjects: 90
Study 26537979 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and Horticultural activity
Number of subjects: 90
Study 23663579 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban and warfarin combined with aspirin and clopidogrel (observation group)
Number of subjects: 505
Study 23663579 — intervention group
Group type: COMPARATOR
Intervention: Aspirin and clopidogrel (control group)
Number of subjects: 505
Study 21410840 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol moistened with normal saline solution (NSS)
Number of subjects: 179
Study 21410840 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol moistened with acetic acid
Number of subjects: 179
Study 19462302 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nicotine replacement therapy (NRT)
Number of subjects: 211
Study 19462302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 211
Study 17456856 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic-floor muscle training (PFMT) regimen 2 to 3 times per week or more
Number of subjects: 0
Study 17456856 — intervention group
Group type: EXPERIMENTAL
Intervention: Task self-efficacy (SE)
Number of subjects: 0
Study 17456856 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulatory self-efficacy (SE)
Number of subjects: 0
Study 17456856 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy scores over time
Number of subjects: 0
Study 15647996 — intervention group
Group type: EXPERIMENTAL
Intervention: polyethylene‐on‐zirconia
Number of subjects: 225
Study 15647996 — intervention group
Group type: EXPERIMENTAL
Intervention: CoCr‐on‐CoCr
Number of subjects: 225
Study 15647996 — intervention group
Group type: EXPERIMENTAL
Intervention: alumina‐on‐alumina
Number of subjects: 225
Study 11494629 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) consisting of conjugated equine estrogens and medroxyprogesterone acetate (MPA)
Number of subjects: 2763
Study 11494629 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated women)
Number of subjects: 2763
Study 9403148 — intervention group
Group type: EXPERIMENTAL
Intervention: Probabilistic reasoning task with emotionally neutral material
Number of subjects: 0
Study 9403148 — intervention group
Group type: EXPERIMENTAL
Intervention: Probabilistic reasoning task with emotional content
Number of subjects: 0
Study 8483425 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens (CEE) 0.625 mg/day over a 25‐day cycle each month (n = 28)
Number of subjects: 118
Study 8483425 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17 beta‐oestradiol 50 micrograms/day over a 24‐day cycle each month (n = 28)
Number of subjects: 118
Study 8483425 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE 0.625 mg/day every day of the month (n = 32)
Number of subjects: 118
Study 8483425 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group, n = 30)
Number of subjects: 118
Study 3087619 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy with Nocardia rubra cell wall skeleton (N-CWS) and Tegafur
Number of subjects: 309
Study 3087619 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy with Tegafur
Number of subjects: 309
Study 3087619 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunochemotherapy with N-CWS and Tegafur
Number of subjects: 309
Study 29289866 — intervention group
Group type: EXPERIMENTAL
Intervention: 6MST
Number of subjects: 61
Study 29289866 — intervention group
Group type: EXPERIMENTAL
Intervention: 4MGS
Number of subjects: 61
Study 29289866 — intervention group
Group type: COMPARATOR
Intervention: 6MWT
Number of subjects: 61
Study 26593273 — intervention group
Group type: EXPERIMENTAL
Intervention: intermittent theta-burst stimulation (iTBS) 1800 pulses/session
Number of subjects: 60
Study 26593273 — intervention group
Group type: COMPARATOR
Intervention: continuous theta-burst stimulation (cTBS) 1800 pulses/session
Number of subjects: 60
Study 26593273 — intervention group
Group type: EXPERIMENTAL
Intervention: combination of cTBS+iTBS, 1800 pulses/session for each
Number of subjects: 60
Study 26593273 — intervention group
Group type: COMPARATOR
Intervention: sham TBS
Number of subjects: 60
Study 24853255 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilization exercises (n = 29)
Number of subjects: 58
Study 24853255 — intervention group
Group type: COMPARATOR
Intervention: Strength and conditioning exercises (n = 29)
Number of subjects: 58
Study 24853255 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Stabilization and Strength and Conditioning)
Number of subjects: 58
Study 22238630 — intervention group
Group type: EXPERIMENTAL
Intervention: DA medication ON condition
Number of subjects: 12
Study 22238630 — intervention group
Group type: COMPARATOR
Intervention: DA medication OFF condition
Number of subjects: 12
Study 19009290 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body low-dose computed tomography (WBLDCT)
Number of subjects: 39
Study 19009290 — intervention group
Group type: COMPARATOR
Intervention: Skeletal survey (SS)
Number of subjects: 39
Study 17220724 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoterate meglumine (Gd-DOTA)
Number of subjects: 0
Study 17220724 — intervention group
Group type: COMPARATOR
Intervention: Nonspecific gadolinium complexes
Number of subjects: 0
Study 15068496 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg/day
Number of subjects: 82
Study 15068496 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 82
Study 12147563 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance-based aerobic exercise for 60 minutes, 3 days a week, for 12 weeks.
Number of subjects: 38
Study 12147563 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 38
Study 7653443 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin therapy (group 3b)
Number of subjects: 112
Study 7653443 — intervention group
Group type: COMPARATOR
Intervention: No anticoagulation (group 3a)
Number of subjects: 112
Study 7653443 — intervention group
Group type: COMPARATOR
Intervention: Population control
Number of subjects: 112
Study 2483958 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexicord (Polfa)
Number of subjects: 32